These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24139794)

  • 1. Olive baboons: a non-human primate model for testing dengue virus type 2 replication.
    Valdés I; Gil L; Castro J; Odoyo D; Hitler R; Munene E; Romero Y; Ochola L; Cosme K; Kariuki T; Guillén G; Hermida L
    Int J Infect Dis; 2013 Dec; 17(12):e1176-81. PubMed ID: 24139794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viremia and antibody response in green monkeys (Chlorocebus aethiops sabaeus) infected with dengue virus type 2: a potential model for vaccine testing.
    Martín J; Hermida L; Castro J; Lazo L; Martínez R; Gil L; Romero Y; Puente P; Zaragoza S; Cosme K; Guzmán MG; Cardosa J; Guillén G
    Microbiol Immunol; 2009 Apr; 53(4):216-23. PubMed ID: 19714858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Macaca radiata as a non-human primate model of Dengue virus infection.
    Kato F; Ishida Y; Kawakami A; Takasaki T; Saijo M; Miura T; Hishiki T
    Sci Rep; 2018 Feb; 8(1):3421. PubMed ID: 29467430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
    Kuruvilla JG; Troyer RM; Devi S; Akkina R
    Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
    Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
    J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viremia and the magnitude of the immune response upon infection of green monkeys with dengue virus type 2 are strain-dependent.
    Martín J; Hermida L; Castro J; Romero Y; Cardosa J; Guillén G
    Curr Microbiol; 2009 Dec; 59(6):579-83. PubMed ID: 19784699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
    Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of interferences between dengue vaccine serotypes in a monkey model.
    Guy B; Barban V; Mantel N; Aguirre M; Gulia S; Pontvianne J; Jourdier TM; Ramirez L; Gregoire V; Charnay C; Burdin N; Dumas R; Lang J
    Am J Trop Med Hyg; 2009 Feb; 80(2):302-11. PubMed ID: 19190230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes.
    Ito M; Katakai Y; Ono F; Akari H; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2011 Jun; 156(6):1073-7. PubMed ID: 21409446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Callithrix penicillata: a feasible experimental model for dengue virus infection.
    Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF
    Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans.
    Moi ML; Takasaki T; Omatsu T; Nakamura S; Katakai Y; Ami Y; Suzaki Y; Saijo M; Akari H; Kurane I
    J Gen Virol; 2014 Mar; 95(Pt 3):591-600. PubMed ID: 24323638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys.
    Kochel TJ; Watts DM; Gozalo AS; Ewing DF; Porter KR; Russell KL
    J Infect Dis; 2005 Mar; 191(6):1000-4. PubMed ID: 15717278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates?
    Valdés I; Gil L; Lazo L; Marcos E; Martín J; Suzarte E; Castro J; Romero Y; Guillén G; Hermida L
    Arch Virol; 2016 Feb; 161(2):465-70. PubMed ID: 26590068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys.
    Farias KJ; Machado PR; Muniz JA; Imbeloni AA; da Fonseca BA
    Viral Immunol; 2015 Apr; 28(3):161-9. PubMed ID: 25664975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models for dengue vaccines and antivirals.
    Plummer EM; Shresta S
    J Immunol Methods; 2014 Aug; 410():34-8. PubMed ID: 24440090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques.
    Koraka P; Benton S; van Amerongen G; Stittelaar KJ; Osterhaus AD
    Vaccine; 2007 Jul; 25(29):5409-16. PubMed ID: 17560694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection.
    Mukherjee S; Pierson TC; Dowd KA
    Methods Mol Biol; 2014; 1138():75-97. PubMed ID: 24696332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques.
    Simmons M; Porter KR; Hayes CG; Vaughn DW; Putnak R
    J Virol; 2006 Oct; 80(19):9577-85. PubMed ID: 16973561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and analysis of dengue virus enhancing and neutralizing activities using simple high-throughput assays.
    Li XQ; Chen J; Huang YF; Ding XX; Liu LD; Qiu LW; Pan YX; Deng YQ; Hu DM; Di B; Qin CF; Che XY
    Appl Microbiol Biotechnol; 2013 Jul; 97(14):6503-11. PubMed ID: 23760532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.